Treatment for Bacteremia with Gram-Positive Cocci in Clusters
Initial Management
- For patients with positive blood cultures showing gram-positive cocci in clusters, empirical therapy with vancomycin should be initiated immediately while awaiting final identification and susceptibility testing, with rapid testing recommended to detect Staphylococcus aureus and determine methicillin susceptibility 1, 2
- Obtain blood cultures before starting antibiotics whenever possible to facilitate de-escalation and rational antibiotic use 1, 2
- When blood cultures show gram-positive cocci in clusters, rapid testing should be performed to detect S. aureus and determine methicillin susceptibility 1, 2
- Empirical therapy should be initiated immediately with coverage for methicillin-resistant S. aureus (MRSA) due to the high prevalence of resistance 3
Empirical Antibiotic Selection
- Vancomycin is the recommended first-line empirical therapy for suspected S. aureus bacteremia while awaiting culture results 4, 3
- Linezolid 600 mg IV/PO twice daily is an alternative option for patients who cannot tolerate vancomycin 4
- Telavancin 10 mg/kg IV once daily is an alternative option for patients who cannot tolerate vancomycin 4
Treatment After Identification and Susceptibility Testing
- For methicillin-susceptible S. aureus (MSSA), switch to an anti-staphylococcal beta-lactam, and the duration of treatment should be 4-6 weeks for native valve infection; at least 6 weeks for prosthetic valve infection 5
- For methicillin-resistant S. aureus (MRSA), continue vancomycin with appropriate dosing to achieve trough levels of 15-20 mg/L 6
- For coagulase-negative staphylococci, if susceptible to methicillin, use an anti-staphylococcal beta-lactam, and if resistant to methicillin, continue vancomycin 6
- Consider removing infected intravascular devices for coagulase-negative staphylococci 3
Duration of Therapy
- For complicated S. aureus bacteremia (endocarditis, metastatic infection), the duration of therapy should be 4-6 weeks 5
- For prosthetic valve infection, the duration of therapy should be at least 6 weeks 5
Monitoring and Follow-up
- Repeat blood cultures daily until sterile to assess treatment adequacy 5
- Monitor vancomycin levels: trough concentrations should be 15-20 mg/L for serious S. aureus infections 6
Source Control
- Remove infected intravascular catheters when possible 3
- For tunnel infections with catheters, consider exchange with a new subcutaneous tunnel or removal 3
Common Pitfalls and Caveats
- Failure to obtain blood cultures before starting antibiotics can significantly reduce pathogen recovery rates 7